- Pfizer and BioNTech announced the results of the effectiveness study for their vaccine and it’s incredibly effective. We were thinking 50% – 60% efficacy was the most likely scenario and scientists were hopeful of a 75% efficacy rate. “The case split between vaccinated individuals and those who received the placebo indicates a vaccine efficacy rate above 90%, at 7 days after the second dose.” https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against
- What’s Next? Look for safety and manufacturing headlines to hit within 2 weeks. “Pfizer and BioNTech are continuing to accumulate safety data and currently estimate that a median of two months of safety data following the second (and final) dose of the vaccine candidate – the amount of safety data specified by the FDA in its guidance for potential Emergency Use Authorization – will be available by the third week of November”
- How many people will be vaccinated? Pfizer expects 50 million vaccine doses by the end of the year to be produced. These will most likely be given to healthcare workers and high risk individuals and seniors at first. They expect 1.3 billion doses in 2021.
- DOW and S&P up big pre-market. Nasdaq up slightly, signifying rotation into beaten down cyclical stocks vs tech which has rallied significantly this year. Expect big moves today.
Tweets and Charts I like:
What I’m looking for:
Biden released his Coronavirus task force this morning too amid the vaccine headlines. Former surgeon general Dr. Vivek Murthy and former Food and Drug Administration commissioner David Kessler will lead the task force. Yale University professor Dr. Marcella Nunez-Smith will also help guide the group. I look forward to learning more about these individuals and their guidance on how to handle the pandemic from now until a vaccine is widely distributed.